Founding Territory Partner – Ophthalmic Device (High Income + Recurring Revenue)
MedCepts Medical Sales & Marketing Network - Medical Devices / Pharmaceuticals · Nashville, TN · 3 mo ago
Business Development$12k–$15k/yrOther
Description
We are building a national team for Optivize, an in-office dry eye procedure that treats the underlying cause of disease—not just symptoms. This is a procedural platform, not a one-time device sale, with built-in recurring revenue from every treated patient.
Compensation
- $5,000 per device placement ($12K–$15K selling price)
- 50% of disposable revenue (practice pays $175 per disposable)
- Ongoing income tied to active accounts
- No cap on earnings—your income grows with account production and adoption
Example
Sell one Optivize unit per month = $60,000. Each of your practices performs 20 procedures per month = $561,600
Total pay = $621,600
Candidate Profile and Call Points
- We are not looking for reps—we are looking for builders.
- We are seeking experienced, independent medical sales reps who already call on ophthalmology, optometry, or other procedure-based private practices. You are comfortable working commission-only and prefer it, because you understand how to build long-term income from producing accounts—not just one-time sales.
- You have experience with capital equipment or procedural device sales and know how to introduce new technology into a clinic. You’re not waiting for leads—you create opportunities, open doors, and drive adoption.
- This is for reps who want to build something meaningful over time. Each placement creates ongoing consumable revenue, and your income grows as your accounts produce. If you’re looking for a quick transaction, this is not it. If you want to develop a portfolio of active, revenue-generating accounts, this is a strong fit.
Call Points
- Opening Hook: “Most dry eye treatments, at best, manage symptoms, but don’t address the underlying cause. Optivize is an in-office procedure designed to fix that.”
- Clinical Differentiation (simple): “For the first time ever, we can clear intraglandular biofilm, allowing the tear glands to function again.”
- Revenue Angle: “This is a procedure-based platform. Practices generate between $600 to $900 per treatment, and it’s repeatable.”
- Workflow Fit: “It integrates easily into existing clinic flow—no major disruption or complex setup.”
- Close for Next Step: “I’d just like 15 minutes to show you how this could fit into your practice. If it makes sense, great—if not, no pressure.”
Territories Available
U.S. territories are open as part of a national rollout. Early partners will have the opportunity to secure and develop their markets.